261 related articles for article (PubMed ID: 22145790)
1. CXCR7 antagonism prevents axonal injury during experimental autoimmune encephalomyelitis as revealed by in vivo axial diffusivity.
Cruz-Orengo L; Chen YJ; Kim JH; Dorsey D; Song SK; Klein RS
J Neuroinflammation; 2011 Dec; 8():170. PubMed ID: 22145790
[TBL] [Abstract][Full Text] [Related]
2. Axial diffusivity is the primary correlate of axonal injury in the experimental autoimmune encephalomyelitis spinal cord: a quantitative pixelwise analysis.
Budde MD; Xie M; Cross AH; Song SK
J Neurosci; 2009 Mar; 29(9):2805-13. PubMed ID: 19261876
[TBL] [Abstract][Full Text] [Related]
3. Exploring experimental autoimmune optic neuritis using multimodal imaging.
Manogaran P; Walker-Egger C; Samardzija M; Waschkies C; Grimm C; Rudin M; Schippling S
Neuroimage; 2018 Jul; 175():327-339. PubMed ID: 29627590
[TBL] [Abstract][Full Text] [Related]
4. Diffusion tensor imaging detects treatment effects of FTY720 in experimental autoimmune encephalomyelitis mice.
Wang X; Brieland JK; Kim JH; Chen YJ; O'Neal J; O'Neil SP; Tu TW; Trinkaus K; Song SK
NMR Biomed; 2013 Dec; 26(12):1742-50. PubMed ID: 23939596
[TBL] [Abstract][Full Text] [Related]
5. Detecting axon damage in spinal cord from a mouse model of multiple sclerosis.
Kim JH; Budde MD; Liang HF; Klein RS; Russell JH; Cross AH; Song SK
Neurobiol Dis; 2006 Mar; 21(3):626-32. PubMed ID: 16298135
[TBL] [Abstract][Full Text] [Related]
6. PI3Kγ inhibition alleviates symptoms and increases axon number in experimental autoimmune encephalomyelitis mice.
Li H; Park D; Abdul-Muneer PM; Xu B; Wang H; Xing B; Wu D; Li S
Neuroscience; 2013 Dec; 253():89-99. PubMed ID: 24012746
[TBL] [Abstract][Full Text] [Related]
7. Diffusion basis spectrum imaging detects and distinguishes coexisting subclinical inflammation, demyelination and axonal injury in experimental autoimmune encephalomyelitis mice.
Wang X; Cusick MF; Wang Y; Sun P; Libbey JE; Trinkaus K; Fujinami RS; Song SK
NMR Biomed; 2014 Jul; 27(7):843-52. PubMed ID: 24816651
[TBL] [Abstract][Full Text] [Related]
8. CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity.
Cruz-Orengo L; Holman DW; Dorsey D; Zhou L; Zhang P; Wright M; McCandless EE; Patel JR; Luker GD; Littman DR; Russell JH; Klein RS
J Exp Med; 2011 Feb; 208(2):327-39. PubMed ID: 21300915
[TBL] [Abstract][Full Text] [Related]
9. ACT-1004-1239, a first-in-class CXCR7 antagonist with both immunomodulatory and promyelinating effects for the treatment of inflammatory demyelinating diseases.
Pouzol L; Baumlin N; Sassi A; Tunis M; Marrie J; Vezzali E; Farine H; Mentzel U; Martinic MM
FASEB J; 2021 Mar; 35(3):e21431. PubMed ID: 33595155
[TBL] [Abstract][Full Text] [Related]
10. Axonal injury detected by in vivo diffusion tensor imaging correlates with neurological disability in a mouse model of multiple sclerosis.
Budde MD; Kim JH; Liang HF; Russell JH; Cross AH; Song SK
NMR Biomed; 2008 Jul; 21(6):589-97. PubMed ID: 18041806
[TBL] [Abstract][Full Text] [Related]
11. Blocking initial infiltration of pioneer CD8(+) T-cells into the CNS via inhibition of SHP-2 ameliorates experimental autoimmune encephalomyelitis in mice.
Luo Q; Sun Y; Gong FY; Liu W; Zheng W; Shen Y; Hua ZC; Xu Q
Br J Pharmacol; 2014 Apr; 171(7):1706-21. PubMed ID: 24372081
[TBL] [Abstract][Full Text] [Related]
12. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
[TBL] [Abstract][Full Text] [Related]
13. [Met
Patel C; Meadowcroft MD; Zagon IS; McLaughlin PJ
Brain Res Bull; 2020 Dec; 165():246-252. PubMed ID: 33141073
[TBL] [Abstract][Full Text] [Related]
14. Estrogen treatment prevents gray matter atrophy in experimental autoimmune encephalomyelitis.
MacKenzie-Graham AJ; Rinek GA; Avedisian A; Morales LB; Umeda E; Boulat B; Jacobs RE; Toga AW; Voskuhl RR
J Neurosci Res; 2012 Jul; 90(7):1310-23. PubMed ID: 22411609
[TBL] [Abstract][Full Text] [Related]
15. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
[TBL] [Abstract][Full Text] [Related]
16. Post-CNS-inflammation expression of CXCL12 promotes the endogenous myelin/neuronal repair capacity following spontaneous recovery from multiple sclerosis-like disease.
Zilkha-Falb R; Kaushansky N; Kawakami N; Ben-Nun A
J Neuroinflammation; 2016 Jan; 13():7. PubMed ID: 26747276
[TBL] [Abstract][Full Text] [Related]
17. Sequential phases of RGC axonal and somatic injury in EAE mice examined using DTI and OCT.
Nishioka C; Liang HF; Barsamian B; Sun SW
Mult Scler Relat Disord; 2019 Jan; 27():315-323. PubMed ID: 30469023
[TBL] [Abstract][Full Text] [Related]
18. HE3286 reduces axonal loss and preserves retinal ganglion cell function in experimental optic neuritis.
Khan RS; Dine K; Luna E; Ahlem C; Shindler KS
Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):5744-51. PubMed ID: 25139738
[TBL] [Abstract][Full Text] [Related]
19. Targeted GAS6 delivery to the CNS protects axons from damage during experimental autoimmune encephalomyelitis.
Gruber RC; Ray AK; Johndrow CT; Guzik H; Burek D; de Frutos PG; Shafit-Zagardo B
J Neurosci; 2014 Dec; 34(49):16320-35. PubMed ID: 25471571
[TBL] [Abstract][Full Text] [Related]
20. Treatment of experimental autoimmune encephalomyelitis with the chemokine receptor antagonist Met-RANTES.
Matsui M; Weaver J; Proudfoot AE; Wujek JR; Wei T; Richer E; Trapp BD; Rao A; Ransohoff RM
J Neuroimmunol; 2002 Jul; 128(1-2):16-22. PubMed ID: 12098506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
